Latin American consensus recommendations on the risk of infections in people with multiple sclerosis treated with disease modifying drugs
Journal
Multiple Sclerosis and Related Disorders
ISSN
2211-0348
Date Issued
2023
Author(s)
Berenice A. Silva
Edgar Carnero Contentti
Jefferson Becker
José I Carranza
Patricio E Correa-Díaz
Lorna Galleguillos Goiry
Orlando Garcea
Fernando Gracia
Fernando Hamuy
Miguel Angel Macías
Carlos Navas
Sebastián Nuñez
Juan I Rojas
Mauricio F. Farez
Ricardo Alonso
Pablo López
Type
Resource Types::text::journal::journal article
Subjects
consensus recommendations
;
disease modifying drugs
;
infections
;
latin america
;
multiple sclerosis
;
consensus
;
covid-19
;
humans
;
latin america
;
multiple sclerosis
;
neurologists
;
alemtuzumab
;
cladribine
;
fingolimod
;
natalizumab
;
ocrelizumab
;
rituximab
;
teriflunomide
;
article
;
clinical practice
;
consensus development
;
coronavirus disease 2019
;
disease association
;
evidence based medicine
;
follow up
;
gastrointestinal infection
;
health care planning
;
human
;
infection risk
;
multiple sclerosis
;
nonhuman
;
opportunistic infection
;
outcome assessment
;
practice guideline
;
progressive multifocal leukoencephalopathy
;
publication
;
respiratory tract infection
;
south and central america
;
standardization
;
treatment planning
;
urogenital tract infection
;
vaccination
;
complication
;
consensus
;
coronavirus disease 2019
;
epidemiology
;
multiple sclerosis
;
neurologist
;
south and central america